ELOVL6-IN-2
ELOVL6-IN-2 is a potent and selective small molecule inhibitor of ELOVL6, suitable for oral administration. It is a valuable research tool for investigating fatty acid metabolism in contexts such as metabolic disorders, non-alcoholic fatty liver disease (NAFLD), and cancer, with utility in both in vitro and in vivo studies.
Product Specifications
CAS Number
1067647-43-1
Product Name Alternative
Plasma, potent, selective, dose-proportionally, liver, inhibit, orally, Inhibitor, ELOVL6, ELOVL6 IN 2, ELOVL6IN2, ELOVL-6-IN-2, ELOVL6-IN-2
Field of Research
Metabolism Research
Purity
99.43% (May vary between batches)
Solubility
10% DMSO+90% Corn Oil:3.3 mg/mL (5.69 mM) ; DMSO:135 mg/mL (232.96 mM)
Smiles
Cc1[nH]n (-c2ccc (OC (F) (F) F) cc2) c (=O) c1C1 (C (=O) N (C2=C1C (=O) CC (C) (C) C2) c1ccccc1) C (F) (F) F
Molecular Formula
C28H23F6N3O4
Molecular Weight
579.49
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cytokeratin, Acidic (Type I or LMW) (Epithelial Marker) (KRTL/1577R), CF647 conjugate, 0.1mg/mL
Beta-Nicotinamide Adenine Dinucleotide Phosphate Sodium Salt Hydrate (~90%)
Annexin A2 (ANXA2) (NM_001002857) Human Over-expression Lysate
TMEM188 (CNEP1R1) (NM_153261) Human Recombinant Protein
MMP3 (Marker of Metastasis and Rheumatoid Arthritis) (MMP3/1994R), 0.2mg/mL
